FGEN insider transaction filings
FIBROGEN INC — 47 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2025-12-09. Screen FGEN transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for FGEN between 2026-06-24 and 2026-09-22. The table below lists the most recent filings on record.
Recent Form 4 filings — FIBROGEN INC
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2025-12-09 | 4 | DeLucia David — Chief Financial Officer | Tax withholding (F): 52 @ $8.42 | EDGAR |
| 2025-12-09 | 4 | Wettig Thane — CEO, Director | Tax withholding (F): 259 @ $8.42 | EDGAR |
| 2025-11-17 | 4 | Wettig Thane — CEO, Director | Purchase (P): 1,000 @ $9.18 · Purchase (P): 2,700 @ $9.10 | EDGAR |
| 2025-09-09 | 4 | DeLucia David — Chief Financial Officer | Tax withholding (F): 51 @ $7.83 · Tax withholding (F): 53 @ $12.10 | EDGAR |
| 2025-09-09 | 4 | Wettig Thane — CEO, Director | Tax withholding (F): 246 @ $7.83 · Tax withholding (F): 248 @ $12.10 | EDGAR |
| 2025-07-02 | 4 | Schoeneck James A — Director | Purchase (P): 23,567 @ $5.07 | EDGAR |
| 2025-06-06 | 4 | Ho Maykin — Director | Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | Schoeneck James A — Director | Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | Kauffman Michael — Director | Grant/award (A): 70,000 (derivative) @ $0 · Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | EDWARDS JEFFREY L — Director | Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
| 2025-03-25 | 4 | Wettig Thane — CEO, Director | Purchase (P): 145,000 @ $0.35 | EDGAR |
| 2025-03-24 | 4 | Schoeneck James A — Director | Purchase (P): 250,000 @ $0.35 · Purchase (P): 50,000 @ $0.34 | EDGAR |
| 2025-03-07 | 4 | DeLucia David — Chief Financial Officer | Tax withholding (F): 2,325 @ $0.39 | EDGAR |
| 2025-03-07 | 4 | Wettig Thane — CEO, Director | Tax withholding (F): 22,038 @ $0.39 · Grant/award (A): 781 @ $0 · Tax withholding (F): 367 @ $0.39 | EDGAR |
| 2025-03-07 | 4 | Chung Christine — SVP, CHINA OPERATIONS | Tax withholding (F): 7,008 @ $0.39 · Grant/award (A): 781 @ $0 · Tax withholding (F): 422 @ $0.39 | EDGAR |
| 2025-01-10 | 4 | DeLucia David — Chief Financial Officer | Grant/award (A): 525,000 (derivative) @ $0 | EDGAR |
| 2025-01-10 | 4 | Wettig Thane — CEO, Director | Grant/award (A): 1,300,000 (derivative) @ $0 | EDGAR |
| 2024-12-09 | 4 | Graham Juan — CHIEF FINANCIAL OFFICER | Tax withholding (F): 1,446 @ $0.34 · Tax withholding (F): 1,066 @ $0.34 | EDGAR |
| 2024-12-09 | 4 | Wettig Thane — CEO, Director | Tax withholding (F): 2,363 @ $0.34 | EDGAR |
| 2024-12-09 | 4 | Chung Christine — SVP, CHINA OPERATIONS | Tax withholding (F): 2,792 @ $0.34 | EDGAR |
| 2024-09-09 | 4 | Graham Juan — CHIEF FINANCIAL OFFICER | Tax withholding (F): 16,050 @ $0.39 · Tax withholding (F): 1,065 @ $0.39 | EDGAR |
| 2024-09-09 | 4 | Wettig Thane — CEO, Director | Tax withholding (F): 2,363 @ $0.39 | EDGAR |
| 2024-09-09 | 4 | Chung Christine — SVP, CHINA OPERATIONS | Tax withholding (F): 17,395 @ $0.39 | EDGAR |
| 2024-08-05 | 4 | Wettig Thane — CEO, Director | Tax withholding (F): 20,840 @ $0.47 | EDGAR |
| 2024-06-25 | 4 | Wettig Thane — CEO, Director | Tax withholding (F): 782 @ $1.13 | EDGAR |
| 2024-06-13 | 4 | Adib Deyaa — Chief Medical Officer | Purchase (P): 22,123 @ $1.17 | EDGAR |
| 2024-06-10 | 4 | Graham Juan — CHIEF FINANCIAL OFFICER | Tax withholding (F): 17,797 @ $1.19 · Tax withholding (F): 1,182 @ $1.10 | EDGAR |
| 2024-06-07 | 4 | Wettig Thane — CEO, Director | Tax withholding (F): 2,255 @ $1.19 | EDGAR |
| 2024-06-07 | 4 | Chung Christine — SVP, CHINA OPERATIONS | Tax withholding (F): 19,289 @ $1.19 | EDGAR |
| 2024-06-06 | 4 | Cravatt Benjamin — Director | Grant/award (A): 70,000 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | Blaug Suzanne — Director | Grant/award (A): 70,000 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | Lema Gerald — Director | Grant/award (A): 70,000 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | Brennan Aoife — Director | Grant/award (A): 70,000 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | Ho Maykin — Director | Grant/award (A): 70,000 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | Schoeneck James A — Director | Grant/award (A): 70,000 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | EDWARDS JEFFREY L — Director | Grant/award (A): 70,000 (derivative) @ $0 | EDGAR |
| 2024-05-02 | 4 | Wettig Thane — CEO, Director | Tax withholding (F): 20,840 @ $1.17 | EDGAR |
| 2024-03-25 | 4 | Wettig Thane — CEO, Director | Tax withholding (F): 782 @ $2.58 | EDGAR |
| 2024-03-11 | 4 | Wettig Thane — CEO | Purchase (P): 50,000 @ $1.91 | EDGAR |
| 2024-03-08 | 4 | Graham Juan — CHIEF FINANCIAL OFFICER | Tax withholding (F): 20,327 @ $1.87 · Grant/award (A): 781 @ $0 · Tax withholding (F): 422 @ $1.87 · Tax withholding (F): 1,181 @ $1.79 | EDGAR |
| 2024-03-08 | 4 | Wettig Thane — CEO | Tax withholding (F): 4,209 @ $1.87 · Grant/award (A): 781 @ $0 · Tax withholding (F): 326 @ $1.87 | EDGAR |
| 2024-03-08 | 4 | Chung Christine — SVP, CHINA OPERATIONS | Tax withholding (F): 23,168 @ $1.87 · Grant/award (A): 781 @ $0 · Tax withholding (F): 422 @ $1.87 | EDGAR |
| 2024-02-23 | 4 | Graham Juan — CHIEF FINANCIAL OFFICER | Grant/award (A): 52,000 @ $0 · Grant/award (A): 260,000 (derivative) @ $0 | EDGAR |
| 2024-02-23 | 4 | Wettig Thane — CEO | Grant/award (A): 166,000 @ $0 · Grant/award (A): 834,000 (derivative) @ $0 | EDGAR |
| 2024-02-23 | 4 | Chung Christine — SVP, CHINA OPERATIONS | Grant/award (A): 29,000 @ $0 · Grant/award (A): 143,000 (derivative) @ $0 | EDGAR |
| 2024-02-05 | 4 | Wettig Thane — CEO | Tax withholding (F): 23,490 @ $2.37 | EDGAR |
| 2023-12-26 | 4 | Wettig Thane — CEO | Tax withholding (F): 819 @ $0.76 | EDGAR |
Recent 8-K events — FIBROGEN INC
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-31 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-16 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-06-09 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-05-11 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-09 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2026-03-16 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-07 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-10 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-06 | 8-K | 8.01 — Other Events | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=FGEN returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →